Press Releases
Weed.de partners with 187 Strassenbande and Marry Jane
BERLIN, GERMANY – [November 27, 2025] – A Weed.de (“Weed”), a digital platform for cannabis information, is reporting on the availability of medicinal cannabis products from the 187 Strassenbande in Germany.
As part of the collaboration, the Weed.de platform will provide editorial coverage of the 187-Sweedz project and offer users information about the journey from cultivation to the final product. The partnership brings together the German hip-hop group 187 Strassenbande, with a consolidated presence in the country's lifestyle scene, and Marry Jane, a cannabis producer with operations in several European markets.
The group, based in Hamburg, developed the cannabis genetics in collaboration with Marry Jane. Each of the five members – Bonez MC, Gzuz, LX, Maxwell, and Sa4 – was involved in the development of a distinct strain. Cultivation takes place in Switzerland.
Marry Jane was founded in 2017 and operates in Switzerland and several EU markets. The collaboration with 187 Strassenbande began with the introduction of a seed line before expanding to the development of a wider range of varieties.
Together, they worked with Swiss growers to create versions of the artists' varieties. Production takes place in Switzerland using manual pruning techniques and suspended drying.
“Cannabis is part of our culture, our music, our identity,” say 187 Strassenbande. “This isn’t a marketing project, it’s something we’ve wanted to do for a long time.”
“This collaboration reflects our mission at Weed.de: to connect culture and progress,” said Richard Cowan, CEO of Weed.de.
“Historically, cannabis varieties have emerged from dialogue between growers and the community – a tradition that continues to shape modern genetics. With the 187 Strassenbande, this story continues.”
For more information, visit weed.de
About Weed.de
Founded in 2023, Weed.de is a consolidated digital information platform covering all topics related to cannabis in Germany. Based on the principles of transparency and accountability, Weed.de empowers cannabis consumers to make informed personal decisions about all aspects of their consumption. Weed.de offers access to reliable and well-founded information and advice, as well as product listings, allowing customers to compare options and access products through partner retailers. From thoroughly researched information to product discovery and purchase support, Weed.de is designed to serve the entire spectrum of cannabis consumers in Germany. Find your way with Weed.de. Weed.de.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
CannaReporter
Michael Sassano: "Approvals can be better streamlined and keep the same rigorous quality standards."
SOMAÍ Pharmaceuticals announced today that it has obtained three Marketing Authorizations (MAs) from Infarmed and...
Spain: Supreme Court accepts pharmacists' appeal against the exclusion of community pharmacies from dispensing cannabis.
The Spanish Supreme Court has accepted the appeal filed by the Consejo General de Colegios de Farmacéuticos (CGCOF) last month...
Infarmed grants three ACMs to SOMAÍ's first medicinal cannabis products in Portugal
Infarmed has granted Marketing Authorizations (MA) to three cannabis-based preparations and substances for the purpose of...
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French patients using medicinal cannabis will continue to receive their treatment for the foreseeable future, as...
Brazil: Anvisa bans CBD purchased from Paraguay by the São Paulo Public Administration; Public Prosecutor's Office investigates.
The Brazilian National Health Surveillance Agency (Anvisa) seized a shipment of cannabidiol (CBD) products last November...
Spain includes medicinal cannabis magistral preparations in the National Formulary
The Spanish Ministry of Health has officially approved the inclusion of standardized compounded cannabis (THC and CBD) solutions...
Norway: AROD asks the International Criminal Court to consider drug prohibition a crime against humanity.
The Alliance for Rights-Oriented Drug Policies (AROD), a Norwegian organization advocating for the revision of drug laws, decided to send a...
Relm Insurance and Prohibition Partners release cannabis risk report for emerging and high-growth industries.
Hamilton, Bermuda — January 15, 2026: Relm Insurance (Relm), a leading insurer focused on emerging industries, today launched...
Spain: Study reveals promising effects of CBD (cannabidiol) in controlling alcoholism.
An investigation by the Spanish National Research Council (CSIC) demonstrates that cannabidiol (CBD) and other components of...
Joana de Almeida Teixeira succeeds João Goulão as president of ICAD.
The Institute for Addictive Behaviors and Dependencies (ICAD) announced this week its new Board of Directors, which...
